Cargando…

Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation

Candida albicans, an opportunistic fungal pathogen, frequently colonizes immune-compromised patients and causes mild to severe systemic reactions. Only few antifungal drugs are currently in use for therapeutic treatment. However, evolution of a drug-resistant C. albicans fungal pathogen is of major...

Descripción completa

Detalles Bibliográficos
Autores principales: Uppar, Vijayakumar, Chandrashekharappa, Sandeep, Shivamallu, Chandan, P, Sushma, Kollur, Shiva Prasad, Ortega-Castro, Joaquín, Frau, Juan, Flores-Holguín, Norma, Basarikatti, Atiyaparveen I., Chougala, Mallikarjun, Mohan M, Mrudula, Banuprakash, Govindappa, Jayadev, Venugopala, Katharigatta N., Nandeshwarappa, Belakatte P., Veerapur, Ravindra, Al-Kheraif, Abdulaziz A., Elgorban, Abdallah M., Syed, Asad, Mudnakudu-Nagaraju, Kiran K., Padmashali, Basavaraj, Glossman-Mitnik, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124935/
https://www.ncbi.nlm.nih.gov/pubmed/34066433
http://dx.doi.org/10.3390/molecules26092722
_version_ 1783693353569746944
author Uppar, Vijayakumar
Chandrashekharappa, Sandeep
Shivamallu, Chandan
P, Sushma
Kollur, Shiva Prasad
Ortega-Castro, Joaquín
Frau, Juan
Flores-Holguín, Norma
Basarikatti, Atiyaparveen I.
Chougala, Mallikarjun
Mohan M, Mrudula
Banuprakash, Govindappa
Jayadev,
Venugopala, Katharigatta N.
Nandeshwarappa, Belakatte P.
Veerapur, Ravindra
Al-Kheraif, Abdulaziz A.
Elgorban, Abdallah M.
Syed, Asad
Mudnakudu-Nagaraju, Kiran K.
Padmashali, Basavaraj
Glossman-Mitnik, Daniel
author_facet Uppar, Vijayakumar
Chandrashekharappa, Sandeep
Shivamallu, Chandan
P, Sushma
Kollur, Shiva Prasad
Ortega-Castro, Joaquín
Frau, Juan
Flores-Holguín, Norma
Basarikatti, Atiyaparveen I.
Chougala, Mallikarjun
Mohan M, Mrudula
Banuprakash, Govindappa
Jayadev,
Venugopala, Katharigatta N.
Nandeshwarappa, Belakatte P.
Veerapur, Ravindra
Al-Kheraif, Abdulaziz A.
Elgorban, Abdallah M.
Syed, Asad
Mudnakudu-Nagaraju, Kiran K.
Padmashali, Basavaraj
Glossman-Mitnik, Daniel
author_sort Uppar, Vijayakumar
collection PubMed
description Candida albicans, an opportunistic fungal pathogen, frequently colonizes immune-compromised patients and causes mild to severe systemic reactions. Only few antifungal drugs are currently in use for therapeutic treatment. However, evolution of a drug-resistant C. albicans fungal pathogen is of major concern in the treatment of patients, hence the clinical need for novel drug design and development. In this study, in vitro screening of novel putative pyrrolo[1,2-a]quinoline derivatives as the lead drug targets and in silico prediction of the binding potential of these lead molecules against C. albicans pathogenic proteins, such as secreted aspartic protease 3 (SAP3; 2H6T), surface protein β-glucanase (3N9K) and sterol 14-alpha demethylase (5TZ1), were carried out by molecular docking analyses. Further, biological activity-based QSAR and theoretical pharmacokinetic analysis were analyzed. Here, in vitro screening of novel analogue derivatives as drug targets against C. albicans showed inhibitory potential in the concentration of 0.4 µg for BQ-06, 07 and 08, 0.8 µg for BQ-01, 03, and 05, 1.6 µg for BQ-04 and 12.5 µg for BQ-02 in comparison to the standard antifungal drug fluconazole in the concentration of 30 µg. Further, in silico analysis of BQ-01, 03, 05 and 07 analogues docked on chimeric 2H6T, 3N9K and 5TZ1 revealed that these analogues show potential binding affinity, which is different from the therapeutic antifungal drug fluconazole. In addition, these molecules possess good drug-like properties based on the determination of conceptual Density Functional Theory (DFT)-based descriptors, QSAR and pharmacokinetics. Thus, the study offers significant insight into employing pyrrolo[1,2-a]quinoline analogues as novel antifungal agents against C. albicans that warrants further investigation.
format Online
Article
Text
id pubmed-8124935
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81249352021-05-17 Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation Uppar, Vijayakumar Chandrashekharappa, Sandeep Shivamallu, Chandan P, Sushma Kollur, Shiva Prasad Ortega-Castro, Joaquín Frau, Juan Flores-Holguín, Norma Basarikatti, Atiyaparveen I. Chougala, Mallikarjun Mohan M, Mrudula Banuprakash, Govindappa Jayadev, Venugopala, Katharigatta N. Nandeshwarappa, Belakatte P. Veerapur, Ravindra Al-Kheraif, Abdulaziz A. Elgorban, Abdallah M. Syed, Asad Mudnakudu-Nagaraju, Kiran K. Padmashali, Basavaraj Glossman-Mitnik, Daniel Molecules Article Candida albicans, an opportunistic fungal pathogen, frequently colonizes immune-compromised patients and causes mild to severe systemic reactions. Only few antifungal drugs are currently in use for therapeutic treatment. However, evolution of a drug-resistant C. albicans fungal pathogen is of major concern in the treatment of patients, hence the clinical need for novel drug design and development. In this study, in vitro screening of novel putative pyrrolo[1,2-a]quinoline derivatives as the lead drug targets and in silico prediction of the binding potential of these lead molecules against C. albicans pathogenic proteins, such as secreted aspartic protease 3 (SAP3; 2H6T), surface protein β-glucanase (3N9K) and sterol 14-alpha demethylase (5TZ1), were carried out by molecular docking analyses. Further, biological activity-based QSAR and theoretical pharmacokinetic analysis were analyzed. Here, in vitro screening of novel analogue derivatives as drug targets against C. albicans showed inhibitory potential in the concentration of 0.4 µg for BQ-06, 07 and 08, 0.8 µg for BQ-01, 03, and 05, 1.6 µg for BQ-04 and 12.5 µg for BQ-02 in comparison to the standard antifungal drug fluconazole in the concentration of 30 µg. Further, in silico analysis of BQ-01, 03, 05 and 07 analogues docked on chimeric 2H6T, 3N9K and 5TZ1 revealed that these analogues show potential binding affinity, which is different from the therapeutic antifungal drug fluconazole. In addition, these molecules possess good drug-like properties based on the determination of conceptual Density Functional Theory (DFT)-based descriptors, QSAR and pharmacokinetics. Thus, the study offers significant insight into employing pyrrolo[1,2-a]quinoline analogues as novel antifungal agents against C. albicans that warrants further investigation. MDPI 2021-05-06 /pmc/articles/PMC8124935/ /pubmed/34066433 http://dx.doi.org/10.3390/molecules26092722 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Uppar, Vijayakumar
Chandrashekharappa, Sandeep
Shivamallu, Chandan
P, Sushma
Kollur, Shiva Prasad
Ortega-Castro, Joaquín
Frau, Juan
Flores-Holguín, Norma
Basarikatti, Atiyaparveen I.
Chougala, Mallikarjun
Mohan M, Mrudula
Banuprakash, Govindappa
Jayadev,
Venugopala, Katharigatta N.
Nandeshwarappa, Belakatte P.
Veerapur, Ravindra
Al-Kheraif, Abdulaziz A.
Elgorban, Abdallah M.
Syed, Asad
Mudnakudu-Nagaraju, Kiran K.
Padmashali, Basavaraj
Glossman-Mitnik, Daniel
Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
title Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
title_full Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
title_fullStr Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
title_full_unstemmed Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
title_short Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
title_sort investigation of antifungal properties of synthetic dimethyl-4-bromo-1-(substituted benzoyl) pyrrolo[1,2-a] quinoline-2,3-dicarboxylates analogues: molecular docking studies and conceptual dft-based chemical reactivity descriptors and pharmacokinetics evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124935/
https://www.ncbi.nlm.nih.gov/pubmed/34066433
http://dx.doi.org/10.3390/molecules26092722
work_keys_str_mv AT upparvijayakumar investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT chandrashekharappasandeep investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT shivamalluchandan investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT psushma investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT kollurshivaprasad investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT ortegacastrojoaquin investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT fraujuan investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT floresholguinnorma investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT basarikattiatiyaparveeni investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT chougalamallikarjun investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT mohanmmrudula investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT banuprakashgovindappa investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT jayadev investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT venugopalakatharigattan investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT nandeshwarappabelakattep investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT veerapurravindra investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT alkheraifabdulaziza investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT elgorbanabdallahm investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT syedasad investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT mudnakudunagarajukirank investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT padmashalibasavaraj investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation
AT glossmanmitnikdaniel investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation